No black box warning on record for Gastrografin

As of the latest FDA labeling reviewed, Gastrografin (DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Gastrografin medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Dehydration: Administration of hypertonic Gastrografin solutions may lead to hypovolemia and hypotension due to fluid loss from the intestine. A 1 in 4.6 (1:4.6) dilution of Gastrografin yields an approximately isotonic 16.5 percent diatrizoate salts solution; less dilute solutions are hypertonic and may lead to intraluminal movement of fluid with resulting hypovolemia. In young or debili

No black box warning on record for Gastrografin

Other warnings & precautions

WARNINGS Dehydration: Administration of hypertonic Gastrografin solutions may lead to hypovolemia and hypotension due to fluid loss from the intestine. A 1 in 4.6 (1:4.6) dilution of Gastrografin yields an approximately isotonic 16.5 percent diatrizoate salts solution; less dilute solutions are hypertonic and may lead to intraluminal movement of fluid with resulting hypovolemia. In young or debili

Gastrografin Black Box Warning

No black box warning on record for Gastrografin

Other warnings & precautions

Gastrografin Black Box Warning

No black box warning on record for Gastrografin

Other warnings & precautions